Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROTEA: Darunavir Monotherapy vs Triple Therapy in HIV
NCT01448707Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Mar 2012
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of darunavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Janssen Pharmaceutical. Started Mar 2012; status: completed.
02
Drugs
darunavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01448707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01448707.